SMAD7 and neoplasm: Additionally, qPCR and IHC staining in subcutaneous tumour xenografts and intraperitoneal nodules showed reduced Smad7 levels in miR-520h-overexpressing tumours, and the opposite results in miR-520-silenced tumours (Fig. 3d, e).